Other recent reports confirm that during the patterning stage optimal levels of FGF2 [ 19] and FGF4 [ 11] correlate with improved foregut specification to pancreatic lineage while inhibiting hepatocyte differentiation, however with more modest outcomes.
However, several studies suggest that web-based self-help interventions without support seem to result in more modest outcomes and considerably higher dropout rates than treatments including regular web-based support from therapists or technically qualified persons [ 6, 8- 10].
When implemented well, radical reforms like SCALE-UP have been shown to lead to higher learning outcomes than more modest reforms (Redish [2003]).
Data from observational studies suggest that unhealthful outcomes can also result from more modest elevations in vitamin A intake (via diet or supplements) over a prolonged time period.
In the meantime, the cost of excessive focus on an unlikely goal could consign to history any opportunity to lock in an agreement for stabilising at 550ppm, a more modest, but still difficult, international outcome.
Early factors played a more modest role for the other outcome entities.
In ESRD, markedly elevated PTH concentrations (>450-600 predictededicted worse outcomes, whereas a more modest increase did not [ 2, 3, 11, 13].
Dyspnoea outcomes suggested a more modest treatment benefit; at the time of the study primary end-point, there was a 25% reduction in the risk of worsening dyspnoea (as measured by a ≥20-point increase in UCSD SOBQ score) or death in the pirfenidone group compared with placebo (hazard ratio 0.75, 95% CI 0.60 0.93; p=0.007).
The outcome — hefty rate hikes or more modest increases — in the pivotal state of California could help shape political races nationwide and the future of enrollment for President Obama's signature law.
Despite the potential risks, sales of dietary supplements for weight loss are booming, in part because the anti-obesity prescription medications remaining on the market -- Xenical and Meridia -- cost more, are rarely covered by insurance and yield only modest outcomes.
(C) Subsequent trials in patients with more long-standing type 2 diabetes, designed primarily to look at the role of intensive glycemic control on cardiovascular outcomes also confirmed a benefit, although more modest, on onset or progression of microvascular complications.
